Physician profile
Robin Williams
NPI 1073556023
$1,365.11
in general payments reported to CMS, 2019-2025
12 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2023: $430 · 2024: $266 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701 · Travel and Lodging: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.76 |
| Travel and Lodging | $517.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $455.14 | 2025 | 1788, Spy-Phi System |
| Leica Microsystems INC. | $380.00 | 2023 | |
| Baxter Healthcare | $146.63 | 2024 | Floseal |
| Hologic INC | $74.48 | 2019 | |
| Integra Lifesciences Corporation | $71.02 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Endomagnetics Ltd | $49.90 | 2023 | Magseed, Magtrace |
| Myriad Genetic Laboratories, INC. | $47.76 | 2024 | Myrisk |
| Astellas Pharma US INC | $37.63 | 2019 | |
| Celgene Corporation | $34.34 | 2019 | |
| Abbvie INC. | $26.29 | 2025 | |
| Glaxosmithkline, LLC. | $24.52 | 2024 | Arexvy, Trelegy Ellipta |
| Hologic Sales and Service, LLC | $17.40 | 2024 | Trident Specimen Radiography System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.